223 related articles for article (PubMed ID: 35929960)
1. Nanotechnology-Inspired Extracellular Vesicles Theranostics for Diagnosis and Therapy of Central Nervous System Diseases.
Tian T; Qiao S; Tannous BA
ACS Appl Mater Interfaces; 2023 Jan; 15(1):182-199. PubMed ID: 35929960
[TBL] [Abstract][Full Text] [Related]
2. Emerging prospects of extracellular vesicles for brain disease theranostics.
Wang R; Wang X; Zhang Y; Zhao H; Cui J; Li J; Di L
J Control Release; 2022 Jan; 341():844-868. PubMed ID: 34953980
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
Shahjin F; Chand S; Yelamanchili SV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
[TBL] [Abstract][Full Text] [Related]
4. Cell membrane-based nanomaterials for theranostics of central nervous system diseases.
Li W; Cheng J; He F; Zhang P; Zhang N; Wang J; Song Q; Hou Y; Gan Z
J Nanobiotechnology; 2023 Aug; 21(1):276. PubMed ID: 37596631
[TBL] [Abstract][Full Text] [Related]
5. Advances in Extracellular Vesicle Nanotechnology for Precision Theranostics.
Wu Q; Fu S; Xiao H; Du J; Cheng F; Wan S; Zhu H; Li D; Peng F; Ding X; Wang L
Adv Sci (Weinh); 2023 Jan; 10(3):e2204814. PubMed ID: 36373730
[TBL] [Abstract][Full Text] [Related]
6. Current progression in application of extracellular vesicles in central nervous system diseases.
Zhang XM; Huang J; Ni XY; Zhu HR; Huang ZX; Ding S; Yang XY; Tan YD; Chen JF; Cai JH
Eur J Med Res; 2024 Jan; 29(1):15. PubMed ID: 38173021
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived extracellular vesicles: Potential diagnostic biomarkers for central nervous system diseases.
Xu X; Iqbal Z; Xu L; Wen C; Duan L; Xia J; Yang N; Zhang Y; Liang Y
Psychiatry Clin Neurosci; 2024 Feb; 78(2):83-96. PubMed ID: 37877617
[TBL] [Abstract][Full Text] [Related]
8. Advanced extracellular vesicle bioinformatic nanomaterials: from enrichment, decoding to clinical diagnostics.
Zhang Y; Zhao L; Li Y; Wan S; Yuan Z; Zu G; Peng F; Ding X
J Nanobiotechnology; 2023 Oct; 21(1):366. PubMed ID: 37798669
[TBL] [Abstract][Full Text] [Related]
9. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders.
Hassanzadeh P; Atyabi F; Dinarvand R
Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367
[TBL] [Abstract][Full Text] [Related]
10. Recent Progress in Isolation and Detection of Extracellular Vesicles for Cancer Diagnostics.
Wang W; Luo J; Wang S
Adv Healthc Mater; 2018 Oct; 7(20):e1800484. PubMed ID: 30009550
[TBL] [Abstract][Full Text] [Related]
11. Advanced Nanotechnologies for Extracellular Vesicle-Based Liquid Biopsy.
Min L; Wang B; Bao H; Li X; Zhao L; Meng J; Wang S
Adv Sci (Weinh); 2021 Oct; 8(20):e2102789. PubMed ID: 34463056
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions.
Choi HK; Chen M; Goldston LL; Lee KB
Nano Converg; 2024 May; 11(1):19. PubMed ID: 38739358
[TBL] [Abstract][Full Text] [Related]
13. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.
Li W; Wang H; Zhao Z; Gao H; Liu C; Zhu L; Wang C; Yang Y
Adv Mater; 2019 Nov; 31(45):e1805344. PubMed ID: 30589111
[TBL] [Abstract][Full Text] [Related]
14. Secreted Extracellular Vesicle Molecular Cargo as a Novel Liquid Biopsy Diagnostics of Central Nervous System Diseases.
Monteiro-Reis S; Carvalho-Maia C; Bart G; Vainio SJ; Pedro J; Silva ER; Sales G; Henrique R; Jerónimo C
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806874
[TBL] [Abstract][Full Text] [Related]
15. Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting.
Muldoon LL; Tratnyek PG; Jacobs PM; Doolittle ND; Christoforidis GA; Frank JA; Lindau M; Lockman PR; Manninger SP; Qiang Y; Spence AM; Stupp SI; Zhang M; Neuwelt EA
AJNR Am J Neuroradiol; 2006 Mar; 27(3):715-21. PubMed ID: 16552023
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles: Therapeutic Potential in Central Nervous System Trauma by Regulating Cell Death.
Chen Y; Zhang H; Hu X; Cai W; Jiang L; Wang Y; Wu Y; Wang X; Ni W; Zhou K
Mol Neurobiol; 2023 Dec; 60(12):6789-6813. PubMed ID: 37482599
[TBL] [Abstract][Full Text] [Related]
17. Imaging as a tool to accelerate the translation of extracellular vesicle-based therapies for central nervous system diseases.
Gao Y; Chu C; Jablonska A; Bulte JWM; Walczak P; Janowski M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1688. PubMed ID: 33336512
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers.
Ramirez SH; Andrews AM; Paul D; Pachter JS
Fluids Barriers CNS; 2018 Jul; 15(1):19. PubMed ID: 29960602
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles for personalized medicine: The input of physically triggered production, loading and theranostic properties.
Piffoux M; Nicolás-Boluda A; Mulens-Arias V; Richard S; Rahmi G; Gazeau F; Wilhelm C; Silva AKA
Adv Drug Deliv Rev; 2019 Jan; 138():247-258. PubMed ID: 30553953
[TBL] [Abstract][Full Text] [Related]
20. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
